Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
Research News
Conference News
Plain English
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
What We Know
Animal Models
Drugs in Trials
Research Tools
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Online Discussions

Updated 6 August 2010
Printable version

Live Discussion: Clinical Care and Research in the Early Stages of Schizophrenia

S. Charles Schulz

Barbara Cornblatt

John Kane

Andrea Auther

Michael O’Sullivan

In the lead-up to next year’s 13th International Congress on Schizophrenia Research in Colorado Springs, Colorado, SRF and the ICOSR will host a series of live discussions on topics of high current interest. This summer we will focus on research that is especially relevant to the clinic with, first, a discussion on the period before or just after the diagnosis of schizophrenia. Later this summer we will take up the topic of comorbidities, specifically schizophrenia and addictive disorders.

ICOSR co-director S. Charles Schulz of the University of Minnesota led a panel that included Barbara Cornblatt of the Albert Einstein College of Medicine, John Kane of North Shore University Hospital and Long Island Jewish Medical Center, Andrea Auther of the Zucker Hillside Hospital, and Michael O’Sullivan of the University of Minnesota in the discussion of recent and current research on the early stages of schizophrenia. This discussion was held in conjunction with the Schizophrenia International Research Society and the International Prodromal Research Network, which will host the Psychosis Satellite Meeting at ICOSR 2011.

View Comments By:
L. Kola Oyewumi — Posted 28 July 2010
Don Linszen — Posted 28 July 2010

Background Text
S. Charles Schulz

Recent years have seen substantial attention focused on the early stages of schizophrenia with a major motivation of understanding the illness before long-term effects of medication treatments and chronicity of illness. As first-episode programs emerged, there came a greater recognition of the clinical utility of early intervention. Examination of the impact of duration of untreated psychosis (DUP) led to a substantial focus on the possibility of diminishing poor outcome in young people with the illness. As the movement in the early stages of schizophrenia through first-episode programs progressed, many clinicians began examining the prodrome—non-specific symptoms preceding the onset of the illness. Work around the world has examined the possibility of psychosocial, nutraceutical, or pharmacologic interventions to diminish prodromal symptoms and even to perhaps forestall the onset of serious psychiatric illness. The purpose of the Webinar presentation will be to examine prodromal programs—including family interventions, to describe a new NIMH-funded trial designed to examine the impact of specific multimodal interventions compared to treatment as usual, and to close with an exploration of recent first-episode brain imaging and neuropsychological testing in the first episode as well as a discussion of family interventions at this stage of disease.

Barbara Cornblatt is director of the RAP (Recognition and Prevention) Program at The Zucker Hillside Hospital, which is a combined treatment and research center. Research focuses on the identification of early biomarkers and risk factors in at-risk adolescents and young adults that predict future psychosis, especially schizophrenia. Prevention of psychosis is the long-range treatment goal of the program. Selection and evaluation of potential treatments are based on research findings, and both pharmacological and psychosocial treatment strategies are currently under study. The program is based on a neurodevelopmental framework, suggesting that there are several different prodromal stages and that treatment should be tailored to the specific needs of the patients, which may differ considerably, depending on whether they are in the early or late stages of the prodrome. In this context, family-focused therapy has several advantages that will be discussed by Andrea Auther, who is the co-director of the RAP Program’s clinical component.

John Kane, Chair of Psychiatry at The Zucker Hillside Hospital, has been involved in the treatment and research of first-episode patients for over two decades. He and his colleagues have reported on the psychobiological characteristics of the first episode and have also published extensively on both short and long-term pharmacologic treatment. Kane now heads a large NIMH-funded intervention study in first-episode schizophrenia and will describe the background and goals of this research.

Charles Schulz, Head of the Department of Psychiatry at the University of Minnesota Medical School, has a long-held interest in the early stages of schizophrenia, beginning with his work with imaging in adolescents with the illness. In this Webinar, Schulz will discuss a multimodal MRI sequence performed in a pilot study with the MIND Research Network to examine differences between first-episode patients and controls, as well as to patients who have had the illness for many years. His colleague, Michael O’Sullivan, will discuss the utility of family psychoeducation to help support parents whose son or daughter has come down with the illness. He will present information on the parents’ response to treatment.

At the conclusion of the Webinar, Schulz, Kane, and Cornblatt will briefly discuss organizations related to their work and the goals of their societies and meetings.

Comments on Online Discussion
Comment by:  L. Kola Oyewumi
Submitted 27 July 2010 Posted 28 July 2010

Thanks for this timely live discussion. Clinical care and...  Read more

View all comments by L. Kola Oyewumi

Comment by:  Don Linszen
Submitted 28 July 2010 Posted 28 July 2010

Is a first psychotic episode program a necessary condition...  Read more

View all comments by Don Linszen
Submit a Comment on This Online Discussion
Make a comment on this live discussion. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
Enter the code as it is shown below:
This code helps prevent automated registrations.

Please note: A member needs to be both registered and logged in to submit a comment.


(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)


SRF News
SRF Comments
Text Size
Reset Text Size
Live Discussion FAQs

Webinar: A Webinar is a seminar conducted remotely over the Web. Attendees view the slides through their Web browser and hear the presentations over their own telephones.

Registration: All participants are to register by clicking on the "Register for the Webinar" link.

Access: After you register, you will receive an e-mail with a link to the Webinar and a phone number.
New Schizophrenia Fact Sheet for Patients and Families

Latest BBRF Research Breakthroughs

Visit our Facebook page and our Blog.

Support the Brain & Behavior Research Foundation Today.

Research Participants
Copyright © 2005- 2016 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright